The Post-Approval Challenge of Global Regulatory Complexity
This article was originally published in The Gold Sheet
Executive Summary
Why industry wants Q12 lifecycle management guideline: 100 regulatory submissions for one post-approval change and other frustrations.
You may also be interested in...
Quality Officers Call For New Approaches To Reduce Global Manufacturing Change Complexity
Pharmaceutical quality leadership proposes eight-step “dance” with complex global regulatory system for allowing manufacturing processes to improve more quickly. The data showed many authorities take more than the recommended six months to decide on post-approval changes, with assessments taking almost eight years in some cases.
ICMRA’s Pilot On Hybrid Inspections And CMC Changes Seeks Participants
Driven by COVID-19 pandemic challenges, regulatory authorities from multiple regions want to work with sponsors on new joint approaches for expediting manufacturing changes globally and streamlining preapproval and pre-licensing inspections.
ICH Seeks To Resolve Impasse Over Q12 Legal Review This Week
It remains uncertain whether a legal review by the European Commission that since June has delayed public consultation of draft ICH Q12 post-approval changes guideline can be resolved during this week's ICH meeting in Geneva.